October 20, 2016 8:46 PM ET


Company Overview of Grifols Therapeutics, Inc.

Company Overview

Grifols Therapeutics, Inc., a biotherapeutic and biotechnology company, engages in discovering, developing, and producing critical care treatments for people with life-threatening disorders. The company offers critical care protein therapies in the areas of immune deficiency, alpha1-antitrypsin (AAT) deficiency, antithrombin III deficiency, hemophilia, hyperimmune globulin therapy, and human albumin. Its products comprise immune globulin-subcutaneous that is used for the treatment of primary immune deficiency; immune globulin-intravenous, which is used for the treatment of neurology/CIDP disorders; plasmin-plasma-derived that is used for the treatment of peripheral arterial occlusion; plasmi...

79 T.W. Alexander Drive

4101 Research Commons

Research Triangle Park, NC 27709

United States

Founded in 2004





Key Executives for Grifols Therapeutics, Inc.

Chairman and Chief Executive Officer
Age: 59
Chief Financial Officer and Executive Vice President
Age: 63
Executive Vice President, Secretary and General Counsel
Age: 64
Senior Vice President and General Manager of Talecris Plasma Resources
Age: 60
Senior Vice President of Information Technology
Age: 61
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Grifols Therapeutics, Inc., please visit www.talecris.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.